Dzwonczyk S[au] - Search Results

Year	Number of Results
1990	5
1991	4
1992	3
1993	7
1994	3
1995	6
1996	5
1997	2
2023	0

1

Cardioselective anti-ischemic ATP-sensitive potassium channel openers.

Atwal KS, Grover GJ, Ahmed SZ, Ferrara FN, Harper TW, Kim KS, Sleph PG, Dzwonczyk S, Russell AD, Moreland S, et al. Atwal KS, et al. Among authors: dzwonczyk s. J Med Chem. 1993 Nov 26;36(24):3971-4. doi: 10.1021/jm00076a027. J Med Chem. 1993. PMID: 8254626 No abstract available.

2

In vitro effects of capsaicin: antiarrhythmic and antiischemic activity.

D'Alonzo AJ, Grover GJ, Darbenzio RB, Hess TA, Sleph PG, Dzwonczyk S, Zhu JL, Sewter JC. D'Alonzo AJ, et al. Among authors: dzwonczyk s. Eur J Pharmacol. 1995 Jan 16;272(2-3):269-78. doi: 10.1016/0014-2999(94)00653-o. Eur J Pharmacol. 1995. PMID: 7713171

3

The cardioprotective and electrophysiological effects of cromakalim are attenuated by meclofenamate through a cyclooxygenase-independent mechanism.

Grover GJ, D'Alonzo AJ, Sleph PG, Dzwonczyk S, Hess TA, Darbenzio RB. Grover GJ, et al. Among authors: dzwonczyk s. J Pharmacol Exp Ther. 1994 May;269(2):536-40. J Pharmacol Exp Ther. 1994. PMID: 8182522

4

Cardioprotective effects of a novel calcium antagonist related to the structure of cromakalim.

Grover GJ, Sleph PG, Dzwonczyk S, McCullough JR. Grover GJ, et al. Among authors: dzwonczyk s. J Pharmacol Exp Ther. 1993 Oct;267(1):102-7. J Pharmacol Exp Ther. 1993. PMID: 8229736

5

Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate.

McCullough JR, Normandin DE, Conder ML, Sleph PG, Dzwonczyk S, Grover GJ. McCullough JR, et al. Among authors: dzwonczyk s. Circ Res. 1991 Oct;69(4):949-58. doi: 10.1161/01.res.69.4.949. Circ Res. 1991. PMID: 1934346

6

Glyburide-reversible cardioprotective effects of calcium-independent phospholipase A2 inhibition in ischemic rat hearts.

Sargent CA, Wilde MW, Dzwonczyk S, Tuttle JG, Murray HN, Atwal K, Grover GJ. Sargent CA, et al. Among authors: dzwonczyk s. Cardiovasc Res. 1996 Feb;31(2):270-7. Cardiovasc Res. 1996. PMID: 8730404

7

Cardioprotective effects of the potassium channel opener cromakalim: stereoselectivity and effects on myocardial adenine nucleotides.

Grover GJ, Newburger J, Sleph PG, Dzwonczyk S, Taylor SC, Ahmed SZ, Atwal KS. Grover GJ, et al. Among authors: dzwonczyk s. J Pharmacol Exp Ther. 1991 Apr;257(1):156-62. J Pharmacol Exp Ther. 1991. PMID: 2019983

8

Comparative anti-ischemic effects of dihydropyridine calcium antagonists in isolated perfused rat hearts: relationship of cardiodepression and cardioprotection.

Grover GJ, Dzwonczyk S, Sleph PG. Grover GJ, et al. Among authors: dzwonczyk s. Pharmacology. 1990;40(3):137-49. doi: 10.1159/000138652. Pharmacology. 1990. PMID: 2333320

9

Cardioprotection in ischemic rat hearts with the SH-containing angiotensin-converting enzyme inhibitor zofenopril: possible involvement of the ATP-sensitive potassium channel.

Sargent CA, Sleph PG, Dzwonczyk S, Smith MA, Normandin D, Antonaccio MJ, Grover GJ. Sargent CA, et al. Among authors: dzwonczyk s. J Pharmacol Exp Ther. 1993 May;265(2):609-18. J Pharmacol Exp Ther. 1993. PMID: 8496812

10

Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.

Grover GJ, Sleph PG, Dzwonczyk S, Wang P, Fung W, Tobias D, Cushman DW. Grover GJ, et al. Among authors: dzwonczyk s. J Pharmacol Exp Ther. 1991 Jun;257(3):919-29. J Pharmacol Exp Ther. 1991. PMID: 1646329

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

35 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year